Keros Therapeutics, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Keros Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Keros Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $277K, a 65.9% increase year-over-year.
  • Keros Therapeutics, Inc. annual Depreciation for 2023 was $815K, a 20.9% increase from 2022.
  • Keros Therapeutics, Inc. annual Depreciation for 2022 was $674K, a 78.3% increase from 2021.
  • Keros Therapeutics, Inc. annual Depreciation for 2021 was $378K, a 36% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $815K +$141K +20.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $674K +$296K +78.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $378K +$100K +36% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $278K +$70K +33.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $208K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.